Advisors to the CDC unanimously recommended Novavax’s COVID-19 vaccine, claiming the unvaxxed are the product’s “primary target population.”
Advisors to the CDC unanimously recommended Novavax’s COVID-19 vaccine, claiming the unvaxxed are the product’s “primary target population.”